⚖
Compare Funds
See how two funds stack up side by side, real returns, risk, cost and portfolio overlap.
VS
Key Metrics Comparison
| Metric | ITI Pharma & Healthcare Fund - Regular Plan - IDCW | HDFC Pharma and Healthcare Fund - Growth - Direct Plan |
|---|---|---|
| Snapshot | ||
| AMC | ITI MF | HDFC MF |
| Category | Equity - Sectoral Fund - Pharma & Health Care | Equity - Sectoral Fund - Pharma & Health Care |
| NAV | ₹17.64 (30 Oct 2026) | ₹21.95 (30 Oct 2026) |
| Rating | ★★★★★ | ★★★★★ |
| Benchmark | Nifty Healthcare Index - TRI | BSE Health Care - TRI |
| Fund Manager | Animesh Singh | Nikhil Mathur |
| Inception | 08 Nov 2021 | 04 Oct 2023 |
| Returns | ||
| 1Y | 6.33% | 22.64% |
| 3Y | 17.82% | 30.41% |
| 5Y | — | — |
| Since Inception | 11.88% | 29.15% |
| Risk | ||
| 14.86 | 14.07 | |
| 0.99 | 0.59 | |
| 0.73 | 1.59 | |
| -2.24 | 21.67 | |
| 1.49 | 3.48 | |
| -10.95% | -9.23% | |
| Costs | ||
| Expense Ratio | 2.62% | 1.03% |
| Exit Load | 0.50% on or before 3M, NIL after 3M | 1% on or before 30D, Nil after 30D |
| Min SIP | ₹500 | ₹100 |
| Min Lumpsum | ₹5,000 | ₹100 |
| Lock-in | None | None |
Min SIP is reported per fund, not per plan, every plan of a fund shares the same figure.
Portfolio Overlap
ITI MF50%
HDFC MF50%
50.4%Only 50.4% of holdings by weight are common between ITI MF and HDFC MF, based on each fund's top 20 disclosed holdings, not the full portfolio.
Common holdingITI MFHDFC MF
Divi's Laboratories Ltd.9.51%9.39%
Sun Pharmaceutical Industries Ltd.11.96%8.28%
Cipla Ltd.4.19%4.15%
Apollo Hospitals Enterprise Ltd.5.45%3.69%
Torrent Pharmaceuticals Ltd.4.78%3.65%
Max Healthcare Institute Ltd.4.49%3.61%
Dr. Reddy's Laboratories Ltd.4.78%3.19%
Alkem Laboratories Ltd.3.09%4.64%
Neuland Laboratories Ltd.3.07%3.24%
Global Health Ltd.2.85%2.72%
Lupin Ltd.2.04%3.55%
Ipca Laboratories Ltd.1.94%2.98%
Shilpa Medicare Ltd.1.61%3.23%
Category context: Equity vs Equity. Open the full Screener →